Redmile Group LLC 13D and 13G filings for Deciphera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:26 pm Purchase |
2023-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 8,359,768 9.900% |
1,251,671 (+17.61%) |
Filing |
| 2023-02-14 4:19 pm Purchase |
2022-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 7,108,097 9.900% |
1,427,180 (+25.12%) |
Filing |
| 2022-05-09 5:15 pm Purchase |
2022-04-29 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 5,680,917 8.100% |
5,016,100 (+754.51%) |
Filing |
| 2022-02-14 5:07 pm Sale |
2021-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 664,817 1.100% |
-3,773,151 (-85.02%) |
Filing |
| 2021-02-16 4:07 pm Sale |
2020-12-31 | 13G | Deciphera Pharmaceuticals, Inc. DCPH |
Redmile Group LLC | 4,437,968 7.800% |
-271,530 (-5.77%) |
Filing |